| 1. |
Deeks J. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ, 2001, 323(7305): 157-162.
|
| 2. |
Oxman A, Guyatt G. Guidelines for reading literature reviews. CMAJ, 1988, 138(8): 697-703.
|
| 3. |
Mulrow C, Linn W, Gaul M, et al. Assessing quality of a diagnostic test evaluation. J Gen Intern Med, 1989, 4(4): 288-295.
|
| 4. |
Guyatt G, Montori V, Devereaux P, et al. Patients at the center: in our practice, and in our use of language. ACP Journal Club, 140(1): A11-2.
|
| 5. |
Hamon M, Biondi-Zoccai G, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. Journal of the American College of Cardiology, 2006, 48(9): 1896-1910.
|
| 6. |
Bossuyt P, Irwig L, Craig J, et al. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ, 2006, 332(7549): 1089-1092.
|
| 7. |
Bossuyt P, Lijmer J, Mol B. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet, 2000, 356(9244): 1844-1847.
|
| 8. |
Mueller C, SCHOLER A, LAULE-KILIAN K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med, 2004, 350(7): 647-654.
|
| 9. |
Moe G, Howlett J, Januzzi J, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation, 2007, 115(24): 3103-3110.
|
| 10. |
Worster A, Preyra I, Weaver B, et al. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Annals of Emergency Medicine, 2002, 40(3): 280-286.
|
| 11. |
Worster A, Haines T. Does replacing intravenous pyelography with noncontrast helical computed tomography benefit patients with suspected acute urolithiasis? Can Assoc Radiol J, 2002, 53(3): 144-148.
|
| 12. |
Guyatt G, Oxman A, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336(7652): 1049-1051.
|
| 13. |
Guyatt G, Oxman A, Kunz R, et al. What is" quality of evidence" and why is it important to clinicians? BMJ, 2008, 336(7651): 995-998.
|
| 14. |
Lord S, Irwig L, Simes R. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine, 2006, 144(11): 850-855.
|
| 15. |
Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, et al. Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 2000, 69 (5): 579-583.
|
| 16. |
Walker FO. Huntington’s disease. Semin Neurol, 2007, 27: 143-150.
|
| 17. |
Almqvist E, Brinkman R, Wiggins S, et al. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 2003, 64(4): 300-309.
|
| 18. |
Rutjes A, Reitsma J, Di Nisio M, et al. Evidence of bias and variation in diagnostic accuracy studies. CMAJ, 2006, 174(4): 469-476.
|
| 19. |
Lijmer J, Mol B, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA, 1999, 282(11): 1061-1066.
|
| 20. |
Bossuyt P, Reitsma J, Bruns D, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med, 2003, 138(1): 40-44.
|
| 21. |
Whiting P, Rutjes A, Reitsma J, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology, 2003, 3: 25.
|
| 22. |
Whiting P, Weswood M, Rutjes A, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 2006, 6: 9.
|
| 23. |
Atkins D, Best D, Briss P, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
|
| 24. |
Schünemann H, Jaeschke R, Cook D, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine, 2006, 174 (5): 605-614.
|
| 25. |
Fletcher R. Carcinoembryonic antigen. Annals of Internal Medicine, 1986, 104(1): 66-73.
|
| 26. |
Hlatky M, Pryor D, Harrell JR F, et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med, 1984, 77(1): 64-71.
|
| 27. |
Levy D, Labib S, Anderson K, et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation, 1990, 81(3): 815-820.
|
